Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy

Diabetologia

Volumn 56, Issue 9, 2013, Pages 2068-2077

  Guan, T H ^a   Chen, G ^a   Gao, B ^a   Janssen, M R ^a   Uttarwar, L ^a   Ingram, A J ^a   Krepinsky, J C ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Caveolae; Caveolin 1; Diabetic nephropathy; Extracellular matrix; RhoA; TGF

Indexed keywords

ADENYLATE KINASE; CAVEOLIN 1; COLLAGEN TYPE 1 A1; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MESANGIUM CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CAVEOLIN 1; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; MALE; MESANGIAL CELLS; MICE; MICE, KNOCKOUT;

EID: 84881612730     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2968-z     Document Type: Article

References (50)

1. Forbes JM, Fukami K, Cooper ME (2007) Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 115:69-84
2. Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius FC III (2008) From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57:1439-1445
3. Zhang Y, Peng F, Gao B, Ingram AJ, Krepinsky JC (2012) High glucose-induced RhoA activation requires caveolae and PKCbeta1-mediated ROS generation. Am J Physiol Renal Physiol 302:F159-F172
4. Peng F, Zhang B, Wu D, Ingram AJ, Gao B, Krepinsky JC (2008) TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Am J Physiol Renal Physiol 295:F153-F164
5. Tamai O, Oka N, Kikuchi T et al (2001) Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis. Kidney Int 59:471-480
6. Parton RG, Simons K (2007) The multiple faces of caveolae. Nat Rev Mol Cell Biol 8:185-194
7. Zhang B, Peng F, Wu D, Ingram AJ, Gao B, Krepinsky JC (2007) Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells. Cell Signal 19:1690-1700
8. Sindhu RK, Ehdaie A, Vaziri ND, Roberts CK (2004) Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. Biochim Biophys Acta 1690:231-237
9. Yamamoto I, Horita S, Takahashi T et al (2008) Caveolin-1 expression is a distinct feature of chronic rejection-induced transplant capillaropathy. Am J Transplant 8:2627-2635
10. Moriyama T, Tsuruta Y, Shimizu A et al (2011) The significance of caveolae in the glomeruli in glomerular disease. J Clin Pathol 64:504-509
11. Razani B, Engelman JA, Wang XB et al (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138
12. Sorensson J, Fierlbeck W, Heider T et al (2002) Glomerular endothelial fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol 13:2639-2647
13. Grande G, Rippe C, Rippe A, Rahman A, Sward K, Rippe B (2009) Unaltered size selectivity of the glomerular filtration barrier in caveolin-1 knockout mice. Am J Physiol Renal Physiol 297:F257-F262
14. Kobayashi M, Sugiyama H, Wang DH et al (2005) Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 68:1018-1031
15. Wu D, Peng F, Zhang B, Ingram AJ, Gao B, Krepinsky JC (2007) Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Diabetologia 50:2008-2018
16. Krepinsky JC, Ingram AJ, Tang D, Wu D, Liu L, Scholey JW (2003) Nitric oxide inhibits stretch-induced MAPK activation in mesangial cells through RhoA inactivation. J Am Soc Nephrol 14:2790-2800
17. Park DS, Cohen AW, Frank PG et al (2003) Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 42:15124-15131
18. Cohen AW, Razani B, Wang XB et al (2003) Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285:C222-C235
19. Woodman SE, Cheung MW, Tarr M et al (2004) Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171:950-957
20. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM (2006) Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290:F214-F222
21. Menne J, Park JK, Boehne M et al (2004) Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Diabetes 53:2101-2109
22. Meier M, Park JK, Overheu D et al (2007) Deletion of protein kinase C-β isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Diabetes 56:346-354
23. Cicha I, Goppelt-Struebe M (2009) Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 35:200-208
24. Peng F, Wu D, Ingram AJ, Zhang B, Gao B, Krepinsky JC (2007) RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction. J Am Soc Nephrol 18:189-198
25. Peng F, Wu D, Gao B et al (2008) RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes 57:1683-1692
26. Kolavennu V, Zeng L, Peng H, Wang Y, Danesh FR (2008) Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57:714-723
27. Gorin Y, Block K, Hernandez J et al (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616-39626
28. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL (1997) Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126
29. Koya D, Haneda M, Nakagawa H et al (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447
30. Kim MY, Lim JH, Youn HH et al (2013) Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice. Diabetologia 56:204-217
31. Chen KH, Hung CC, Hsu HH, Jing YH, Yang CW, Chen JK (2011) Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-beta/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem Biol Interact 190:45-53
32. Levine YC, Li GK, Michel T (2007) Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK -> Rac1 ->Akt -> endothelial nitric-oxide synthase pathway. J Biol Chem 282:20351-20364
33. Demova H, Komers R (2009) Determination of caveolin-1 in renal caveolar and non-caveolar fractions in experimental type 1 diabetes. Physiol Res 58:563-568
34. Castello-Cros R, Whitaker-Menezes D, Molchansky A et al (2011) Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle 10:2140-2150
35. Murata T, Lin MI, Huang Y et al (2007) Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204:2373-2382
36. Tourkina E, Richard M, Oates J et al (2010) Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis 69:1220-1226
37. Tourkina E, Richard M, Gooz P et al (2008) Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 294:L843-L861
38. Wang XM, Zhang Y, Kim HP et al (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203:2895-2906
39. Shivshankar P, Brampton C, Miyasato S, Kasper M, Thannickal VJ, Le Saux CJ (2012) Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Am J Respir Cell Mol Biol 47:28-36
40. Park HC, Yasuda K, Ratliff B et al (2010) Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol 298:F357-F364
41. Kim S, Lee Y, Seo JE, Cho KH, Chung JH (2008) Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell Signal 20:1313-1319
42. Taraboletti G, D'Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160:673-680
43. Sottile J, Chandler J (2005) Fibronectin matrix turnover occurs through a caveolin-1-dependent process. Mol Biol Cell 16:757-768
44. Wyse BD, Prior IA, Qian H et al (2003) Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane. J Biol Chem 278:23738-23746
45. Moore J, McKnight AJ, Simmonds MJ et al (2010) Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA 303:1282-1287
46. Testa A, Spoto B, Sanguedolce MC et al (2012) eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients. Am J Hypertens 25:103-108
47. Grayson TH, Ohms SJ, Brackenbury TD et al (2007) Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets. BMC Genomics 8:404
48. Tourkina E, Hoffman S (2012) Caveolin-1 signaling in lung fibrosis. Open Rheumatol J 6:116-122
49. Chidlow JH Jr, Greer JJ, Anthoni C et al (2009) Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis. Gastroenterology 136:575-584
50. Bernatchez P, Sharma A, Bauer PM, Marin E, Sessa WC (2011) A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. J Clin Invest 121:3747-3755